Skip to main content
Clinical Trials/NCT01363362
NCT01363362
Completed
Not Applicable

Effect of Selective Lasertrabeculoplasty (SLT) on Ocular Hemodynamics in Glaucoma

Technische Universität Dresden1 site in 1 country150 target enrollmentDecember 2010
ConditionsGlaucoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Glaucoma
Sponsor
Technische Universität Dresden
Enrollment
150
Locations
1
Primary Endpoint
Change in ocular hemodynamics after Selective Laser Trabeculoplasty (SLT)
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Selective Laser Trabeculoplasty (SLT) is known to reduce intraocular pressure in glaucoma patients. This study investigates, if there are changes in different ocular hemodynamic parameters prior and after SLT.

Detailed Description

Ocular blood flow, ocular pulse amplitude and ocular pulse volume are measured with the Blood Flow Analyzer (Paradigm Medical Industries, Inc.) prior and 3 month after SLT.

Registry
clinicaltrials.gov
Start Date
December 2010
End Date
August 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Karin Pillunat

Principal Investigator

Technische Universität Dresden

Eligibility Criteria

Inclusion Criteria

  • glaucoma patient
  • over 18 years
  • needs further intraocular pressure regulation

Exclusion Criteria

  • age under 18 years
  • debilitated
  • no glaucoma

Outcomes

Primary Outcomes

Change in ocular hemodynamics after Selective Laser Trabeculoplasty (SLT)

Time Frame: baseline and 3 month

Pulsatile ocular blood flow, ocular pulse amplitude and ocular pulse volume are measured prior and 3 month after SLT with the Blood Flow Analyzer (Paradigm Medical Industries, Inc.)

Study Sites (1)

Loading locations...

Similar Trials